News

SecureCell launches Numera 3 sampling system

Urdorf, Zurich — SecureCell has launched the Numero 3 automated sampling system. The system enables laboratories to reduce their manual workload and generate more reliable data. A webinar on October 15 will discuss the advantages of the Numero 3 system. The biotech company SecureCell AG, based in Urdorf, has further developed...

read more

Topadur Pharma AG Secures FDA Orphan Drug Designation for TOP-N53 Targeting Digital Ulcers in Systemic Sclerosis

Topadur Pharma AG today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational therapy TOP-N53 for the treatment of digital ulcersin patients with systemic sclerosis. Systemic sclerosis is a rare, life-threatening autoimmune disease characterized by fibrosis, vascular damage, and chronic digital ulcers that...

read more

InSphero Appoints Werner Lanthaler to Its Board of Directors

InSphero AG, the pioneer in scalable 3D in vitro technologies for drug safety and efficacy testing, announced the appointment of Dr. Werner Lanthaler, Managing Director of Wlanholding GmbH, former Chief Executive Officer of Evotec SE, and former CFO of Intercell AG, to its Board of Directors. Dr. Lanthaler led Evotec for 16 years, during which he guided the...

read more

Neurimmune drug for ALS nears approval

AL-S Pharma today announced positive topline results from the Phase 2 clinical study evaluating AP-101, a potential first-in-class, disease-modifying treatment for amyotrophic lateral sclerosis (ALS). AP-101 is a monoclonal antibody targeting misfolded SOD1, a key pathology in both sporadic ALS and mutant SOD1-ALS.1 AP-101, in addition to standard of care, met...

read more